On election day, Tuesday, November 5, Americans will choose between former President Donald Trump and current Vice President ...

Morgan Stanley lowered the firm’s price target on Zenas BioPharma (ZBIO) to $35 from $40 and keeps an Overweight rating on the shares. The firm ...

The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

Analyst Derek Archila of Wells Fargo assigned a Hold rating on Sutro Biopharma (STRO – Research Report), with a price target of $4.00.Pick the ...

GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.

Sutro Biopharma Inc (STRO) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.46 or -16.37% from the prior close of $2.81. The stock opened at $2.79 and touched a low of ...

As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

As part of an SEC settlement, a Houston pharmaceutical company won't have to pay a civil penalty — but two of its former top ...

With the China-targeting Biosecure Act absent from a key defense spending bill revealed over the weekend, it appears the ...

Veradermics Inc., a New Haven-based biopharmaceutical company, said Wednesday it has closed a $75 million Series B financing ...

Vor Biopharma Inc (VOR) stock saw a modest uptick, ending the day at $1.04 which represents a slight increase of $0.22 or 26.83% from the prior close of $0.82. The stock opened at $0.86 and touched a ...